{"id":63554,"date":"2025-11-17T21:02:37","date_gmt":"2025-11-17T20:02:37","guid":{"rendered":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/"},"modified":"2025-11-17T21:02:37","modified_gmt":"2025-11-17T20:02:37","slug":"arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta","status":"publish","type":"post","link":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/","title":{"rendered":"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta"},"content":{"rendered":"<p>    <video-js id=\"videojs69ea67723ba79\" class=\"vjs-big-play-centered\" controls preload=\"auto\" playsinline data-setup='{\"fluid\": true}'>\r\n        <source src=\"https:\/\/video.italpress.com\/play\/mp4\/video\/WXOx\" type=\"video\/mp4\" \/>\r\n    <\/video-js>\r\n           <br \/>\n<\/p>\n<div> MILANO (ITALPRESS) &#8211; Nuove speranze per i pazienti affetti da Leucemia Mieloide Acuta, un tumore aggressivo del sangue e del midollo osseo caratterizzato da una rapida progressione che colpisce ogni anno 2.000 persone in Italia. Daiichi Sankyo ha infatti annunciato la disponibilit\u00e0 nel nostro Paese di quizartinib, primo farmaco in ematologia lanciato in Italia dalla casa farmaceutica giapponese.<br \/>\nxs1\/f20\/fsc\/gtr<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MILANO (ITALPRESS) &#8211; Nuove speranze per i pazienti affetti da Leucemia Mieloide Acuta, un tumore aggressivo del sangue e del midollo osseo caratterizzato da una rapida progressione che colpisce ogni anno 2.000 persone in Italia. Daiichi Sankyo ha infatti annunciato la disponibilit\u00e0 nel nostro Paese di quizartinib, primo farmaco in ematologia lanciato in Italia dalla [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":63555,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"jnews_post_split":[],"footnotes":""},"categories":[1171],"tags":[],"class_list":["post-63554","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-video","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta - Live Magazine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta - Live Magazine\" \/>\n<meta property=\"og:description\" content=\"MILANO (ITALPRESS) &#8211; Nuove speranze per i pazienti affetti da Leucemia Mieloide Acuta, un tumore aggressivo del sangue e del midollo osseo caratterizzato da una rapida progressione che colpisce ogni anno 2.000 persone in Italia. Daiichi Sankyo ha infatti annunciato la disponibilit\u00e0 nel nostro Paese di quizartinib, primo farmaco in ematologia lanciato in Italia dalla [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/\" \/>\n<meta property=\"og:site_name\" content=\"Live Magazine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LiveMag\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-17T20:02:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/ograph.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"italpress\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@LiveNotizie\" \/>\n<meta name=\"twitter:site\" content=\"@LiveNotizie\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"italpress\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/\"},\"author\":{\"name\":\"italpress\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#\\\/schema\\\/person\\\/b62c5f44451fdcdaeb0afe6c2424e73c\"},\"headline\":\"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta\",\"datePublished\":\"2025-11-17T20:02:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/\"},\"wordCount\":84,\"publisher\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.livemag.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/WXOx.jpg\",\"articleSection\":[\"Video\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/\",\"url\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/\",\"name\":\"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta - Live Magazine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.livemag.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/WXOx.jpg\",\"datePublished\":\"2025-11-17T20:02:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.livemag.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/WXOx.jpg\",\"contentUrl\":\"https:\\\/\\\/www.livemag.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/WXOx.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/2025\\\/11\\\/17\\\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.livemag.it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#website\",\"url\":\"https:\\\/\\\/www.livemag.it\\\/\",\"name\":\"Live Magazine\",\"description\":\"Varie ed eventi\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.livemag.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#organization\",\"name\":\"LiveMag\",\"alternateName\":\"LiveMag News ed eventi\",\"url\":\"https:\\\/\\\/www.livemag.it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.livemag.it\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/immagine-sito.jpg\",\"contentUrl\":\"https:\\\/\\\/www.livemag.it\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/immagine-sito.jpg\",\"width\":696,\"height\":696,\"caption\":\"LiveMag\"},\"image\":{\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/LiveMag\\\/\",\"https:\\\/\\\/x.com\\\/LiveNotizie\",\"https:\\\/\\\/www.instagram.com\\\/livemag\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.livemag.it\\\/#\\\/schema\\\/person\\\/b62c5f44451fdcdaeb0afe6c2424e73c\",\"name\":\"italpress\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6a21695fc713ce7ee312cf57c97e2e641feb365be72d8745574d3c3e2b59066?s=96&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6a21695fc713ce7ee312cf57c97e2e641feb365be72d8745574d3c3e2b59066?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6a21695fc713ce7ee312cf57c97e2e641feb365be72d8745574d3c3e2b59066?s=96&r=g\",\"caption\":\"italpress\"},\"description\":\"Italpress \u00e8 un'agenzia di stampa italiana a carattere nazionale.\",\"url\":\"https:\\\/\\\/www.livemag.it\\\/index.php\\\/author\\\/italpress\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta - Live Magazine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/","og_locale":"it_IT","og_type":"article","og_title":"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta - Live Magazine","og_description":"MILANO (ITALPRESS) &#8211; Nuove speranze per i pazienti affetti da Leucemia Mieloide Acuta, un tumore aggressivo del sangue e del midollo osseo caratterizzato da una rapida progressione che colpisce ogni anno 2.000 persone in Italia. Daiichi Sankyo ha infatti annunciato la disponibilit\u00e0 nel nostro Paese di quizartinib, primo farmaco in ematologia lanciato in Italia dalla [&hellip;]","og_url":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/","og_site_name":"Live Magazine","article_publisher":"https:\/\/www.facebook.com\/LiveMag\/","article_published_time":"2025-11-17T20:02:37+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/ograph.jpg","type":"image\/jpeg"}],"author":"italpress","twitter_card":"summary_large_image","twitter_creator":"@LiveNotizie","twitter_site":"@LiveNotizie","twitter_misc":{"Scritto da":"italpress"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/#article","isPartOf":{"@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/"},"author":{"name":"italpress","@id":"https:\/\/www.livemag.it\/#\/schema\/person\/b62c5f44451fdcdaeb0afe6c2424e73c"},"headline":"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta","datePublished":"2025-11-17T20:02:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/"},"wordCount":84,"publisher":{"@id":"https:\/\/www.livemag.it\/#organization"},"image":{"@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/#primaryimage"},"thumbnailUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2025\/11\/WXOx.jpg","articleSection":["Video"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/","url":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/","name":"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta - Live Magazine","isPartOf":{"@id":"https:\/\/www.livemag.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/#primaryimage"},"image":{"@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/#primaryimage"},"thumbnailUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2025\/11\/WXOx.jpg","datePublished":"2025-11-17T20:02:37+00:00","breadcrumb":{"@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/#primaryimage","url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2025\/11\/WXOx.jpg","contentUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2025\/11\/WXOx.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.livemag.it\/index.php\/2025\/11\/17\/arriva-una-nuova-opzione-terapeutica-per-i-pazienti-con-leucemia-mieloide-acuta\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.livemag.it\/"},{"@type":"ListItem","position":2,"name":"Arriva una nuova opzione terapeutica per i pazienti con Leucemia Mieloide Acuta"}]},{"@type":"WebSite","@id":"https:\/\/www.livemag.it\/#website","url":"https:\/\/www.livemag.it\/","name":"Live Magazine","description":"Varie ed eventi","publisher":{"@id":"https:\/\/www.livemag.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.livemag.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.livemag.it\/#organization","name":"LiveMag","alternateName":"LiveMag News ed eventi","url":"https:\/\/www.livemag.it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.livemag.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/immagine-sito.jpg","contentUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/immagine-sito.jpg","width":696,"height":696,"caption":"LiveMag"},"image":{"@id":"https:\/\/www.livemag.it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LiveMag\/","https:\/\/x.com\/LiveNotizie","https:\/\/www.instagram.com\/livemag\/"]},{"@type":"Person","@id":"https:\/\/www.livemag.it\/#\/schema\/person\/b62c5f44451fdcdaeb0afe6c2424e73c","name":"italpress","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/b6a21695fc713ce7ee312cf57c97e2e641feb365be72d8745574d3c3e2b59066?s=96&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b6a21695fc713ce7ee312cf57c97e2e641feb365be72d8745574d3c3e2b59066?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b6a21695fc713ce7ee312cf57c97e2e641feb365be72d8745574d3c3e2b59066?s=96&r=g","caption":"italpress"},"description":"Italpress \u00e8 un'agenzia di stampa italiana a carattere nazionale.","url":"https:\/\/www.livemag.it\/index.php\/author\/italpress\/"}]}},"jetpack_featured_media_url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2025\/11\/WXOx.jpg","_links":{"self":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/posts\/63554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/comments?post=63554"}],"version-history":[{"count":0,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/posts\/63554\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/media\/63555"}],"wp:attachment":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/media?parent=63554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/categories?post=63554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/tags?post=63554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}